PubMed Health⌕ Search

Biomedical subjects

K Buckshee

Publications and source records attributed to K Buckshee.

At least 73 records · Page 4Linked to original sources
PubMed1987

Clinical evaluation of steroid receptors in ovarian neoplasms.

Estrogen and progesterone receptors were estimated in a total of 25 ovarian neoplasms. None of the benign tumors showed steroid receptors. In malignant tumors serous tumors were more often receptor positive than the mucinous. Receptor levels were correlated with the staging of the disease, menstrual status and the resectability of the tumor. The response to chemotherapeutic drugs was better in patients with low estrogen and progesterone receptors as compared to those with high levels. The latter group showed a definite response to progesterone treatment in vitro. These are the group of patients who may benefit by combination of hormones and chemotherapeutic drugs.

Cystadenoma↗
PubMed1987

Ultrasound detection of antenatal meconium.

A new method for antenatal diagnosis of the presence of meconium in the amniotic cavity is reported. Ultrasonographic placental grading is a routine procedure in the monitoring of high-risk pregnancy. During serial scans of 58 patients, it was noted that in 11 cases placental grading was impossible after a certain period. At delivery, thick meconium was noted in all these cases.

Adult↗
PubMed1985

Status of autoantibodies to zona pellucida in human reproduction.

The sera of 80 patients were tested by the indirect immunofluorescence technique to evaluate the presence of autoantibodies to zona pellucida in human reproduction. The incidence of positive anti-zona activity was 71.4% (25/35) in the infertile women, 40.0% (6/15) in the normal, nonpregnant fertile women, 20.0% (3/15) in the normal pregnant women and 26.7% (4/15) in the normal fertile men, when unabsorbed sera were tested. To overcome false positive reactions due to nonspecific serum components, all the positive sera were absorbed with formalinized porcine red blood cells and retested. However, after absorption, anti-zona activity was lost in all the positive sera from non-pregnant fertile women, pregnant women and fertile men; but it was retained in 51.4% (18/35) of the infertile women. These positive sera (18) were further absorbed with zona-coated eggs and retested. Fluorescence was lost in all the positive sera, thus demonstrating the presence of antibodies specific to zona antigen in the infertile women. The study also revealed that autoantibodies to zona were seen more often in patients of greater age (26 to 40 years) and in those who had been infertile for a greater period of time (greater than 6 years).

Adolescent↗
PubMed1984

Autoantibodies to zona pellucida in tubectomized women.

khe study was conducted to detect autoantibodies to zona pellucida by indirect immunofluorescence technique. A total of 60 human sera was examined, which included 15 tubectomized , 15 pregnant, 15 nonpregnant fertile women, and 15 fertile men. In the unabsorbed sera, anti-zona activity was observed in 53.3% of the tubectomized women and in 40.0% of the nonpregnant fertile women, 20.0% of the pregnant women and 26.7% of the fertile men. All the positive sera were then absorbed with porcine red blood cells and retested to exclude the false positive reaction due to nonspecific serum components. After absorption, immunological response was retained in 26.7% of the tubectomized women and lost in all the other women and men. The positive sera were further absorbed with zona-coated eggs and were retested. Fluorescence was lost in all the positive sera. This observation demonstrates the presence of antibodies, specific to zona antigens, in tubectomized women. To date, however, antibodies to zona antigen have not been demonstrated in the tubectomized women. Presence of anti-zona activity in tubectomized women may be an autoimmune response, possibly due to absorption and degradation of the ova into the peritoneal cavity or in the reproductive tract and the subsequent exposure of the degradation products to the immune system.

Autoantibodies↗
PubMed1984

Use of in vitro method to predict response of human ovarian carcinoma cells to chemotherapeutic agents.

In vitro tissue culture and sensitivity tests were carried out on 16 cases of ovarian cancer to select the right anticancer drug(s) on an individual basis. The predictive accuracy of the in vitro drug sensitivity tests were 81.8%. The drug(s) suggested by in vitro tests did not reveal any correlation to the type of ovarian cancer. The drug sensitivity of cells from primary growth was different from that of secondary growth. The in vitro screening test also provided the choice of the next best drug(s), once the tumor had become resistant to a particular drug(s). Thus, the overall prognosis of patients at an advanced stage of malignancy could be improved with the help of in vitro predictive tests.

Adenocarcinoma, Mucinous↗